GM2 Activator

Protein Deficiency

Learn more about GM2 activator protein deficiency.

There is Some Evidence for Several Onset Levels of GM2 Activator Protein Deficiency

GM2 activator protein deficiency is an ultra-rare disease with less than 30 patients ever reported worldwide.

Some evidence does exist indicating that there may be three forms of this disease, including infantile, juvenile, and late-onset, similarly to Tay-Sachs disease.

What is GM2 Activator Protein Deficiency?

GM2 activator protein deficiency, commonly referred to as GM2 AB Variant, is an extremely rare autosomal recessive lysosomal storage disorder caused by deficiency of the GM2 ganglioside activator protein, due to variants (mutations) in the GM2A gene. The GM2A gene encodes the GM2 ganglioside activator, which is required for the lysosomal enzyme beta-hexosaminidase A (HexA) to break down GM2 ganglioside.

We’re Here to Help You

Getting a diagnosis can be overwhelming. It’s hard to know what to do first. Our Family Services Team is here to help. They’ll answer your questions, share information, and invite you to connect with our caring and helpful Community.

Research

Learn about ongoing studies, clinical trials, funding opportunities, and research initiatives, and browse our research library.

Family Support

Connect with our Family Services Team who will answer your questions and share resources for your specific situation.

We Care for Rare

Learn more about Rare Families and their stories through our We Care for Rare section.